Harvest Fund Management Co. Ltd Sells 1,892 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Harvest Fund Management Co. Ltd reduced its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 35.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,406 shares of the aerospace company’s stock after selling 1,892 shares during the period. Harvest Fund Management Co. Ltd’s holdings in Leidos were worth $555,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Atria Investments Inc increased its position in shares of Leidos by 100.1% during the third quarter. Atria Investments Inc now owns 8,837 shares of the aerospace company’s stock worth $1,440,000 after buying an additional 4,421 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Leidos by 51.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock worth $136,491,000 after acquiring an additional 283,558 shares during the period. Los Angeles Capital Management LLC grew its holdings in Leidos by 21.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 55,165 shares of the aerospace company’s stock worth $8,992,000 after acquiring an additional 9,710 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its position in shares of Leidos by 188.2% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,274 shares of the aerospace company’s stock worth $1,207,000 after acquiring an additional 5,403 shares in the last quarter. Finally, AQR Capital Management LLC lifted its stake in shares of Leidos by 76.9% in the 2nd quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock valued at $101,942,000 after purchasing an additional 303,775 shares during the period. 76.12% of the stock is owned by institutional investors and hedge funds.

Leidos Trading Up 1.5 %

Shares of Leidos stock opened at $166.04 on Wednesday. The company has a market capitalization of $22.15 billion, a P/E ratio of 18.91, a price-to-earnings-growth ratio of 1.11 and a beta of 0.68. The stock has a fifty day simple moving average of $170.77 and a 200 day simple moving average of $156.57. Leidos Holdings, Inc. has a 12-month low of $105.52 and a 12-month high of $202.90. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.87.

Leidos (NYSE:LDOS) last posted its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The firm had revenue of $4.19 billion during the quarter, compared to analyst estimates of $4.06 billion. During the same quarter in the prior year, the business posted $2.03 EPS. The business’s revenue was up 6.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Leidos Holdings, Inc. will post 10.04 earnings per share for the current fiscal year.

Leidos Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.96%. This is a boost from Leidos’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Monday, December 16th. Leidos’s payout ratio is presently 18.22%.

Insider Buying and Selling

In related news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the transaction, the director now owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. The trade was a 14.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Surya N. Mohapatra sold 2,748 shares of the business’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $194.97, for a total value of $535,777.56. Following the transaction, the director now owns 20,001 shares of the company’s stock, valued at approximately $3,899,594.97. The trade was a 12.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

LDOS has been the subject of several recent analyst reports. Robert W. Baird raised their price objective on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. TD Cowen raised their price target on shares of Leidos from $175.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, October 30th. Royal Bank of Canada upped their price objective on shares of Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a report on Wednesday, October 30th. Wells Fargo & Company cut their price objective on shares of Leidos from $230.00 to $205.00 and set an “overweight” rating on the stock in a research report on Tuesday. Finally, Truist Financial decreased their target price on Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a research report on Friday, November 22nd. Two equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Leidos currently has an average rating of “Moderate Buy” and a consensus price target of $187.77.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.